Navigation Links
IPS Appoints Dave Wareheim as Bioprocess Subject Matter Expert
Date:1/20/2010

Integrated Project Services (IPS), a leading, full-service engineering, construction, commissioning and qualification company dedicated to assisting life science companies execute technically complex projects, today announced the appointment of Dave Wareheim as Bioprocess Subject Matter Expert.

Lafayette Hill, PA (Vocus) January 20, 2010 -- Integrated Project Services (IPS), a leading, full-service engineering, construction, commissioning and qualification company dedicated to assisting life science companies execute technically complex projects, today announced the appointment of Dave Wareheim as Bioprocess Subject Matter Expert. In this role, Mr. Wareheim will leverage his extensive industry insight and knowledge of operations, simulation and throughput analysis, process development, process engineering, process architecture and overall process consultancy.

"Dave brings an in-depth knowledge of cell culture processes and the design/implementation of Single-Use (SU) technologies; this knowledge will significantly improve operational capabilities, throughput and process control for our pre-clinical, clinical and commercial manufacturing customers,” said Dave Goswami, P.E., President and Chief Operating Officer, IPS. “His combined experience in large biotech projects and SU systems is unmatched in the architectural/ engineering (A/E) side of the business. Dave joining the IPS team really balances our existing strengths in process architecture, equipment and execution of process projects with knowledge of cell culture science and operations, enhancing IPS’ position as a top tier provider of bioprocess engineering services.”

Mr. Wareheim brings over thirty years of experience as a bioprocess subject matter expert for global small and large scale Research & Development (R&D) and commercial manufacturing projects. For the last 8 years, he was with Centocor-Ortho Biotech as Master Engineering Fellow and was responsible for the process implementation of SU biotechnologies in both upstream and downstream operations. He led an effort to streamline downstream processing that ultimately led to patent submission and design/build of a first ever system. Previously, Mr. Wareheim worked as a Senior Process Engineering Specialist where he provided process consulting on the design, implementation and qualification of bioreactors, automated UF/DF, and other biotechnology operations. At SmithKline Beecham, Mr. Wareheim was a Computer Process Systems Manager responsible for the design, implementation and qualification of bioreactors, equipment and downstream units. He began his career as a Staff Scientist with the Frederick Cancer Research Center (FCRC) where he designed and executed bench scale isolation of anti-tumor anti-neoplastics.

Mr. Wareheim earned a Bachelor of Science degree in Biology from Towson State University. Considered an expert in disposable technology and fermentation, he has presented at numerous meetings and conferences and has written numerous technical manuscripts and book chapters.

About IPS
Integrated Project Services (IPS), www.ipsdb.com, is a full-service engineering firm dedicated to helping clients succeed with capital projects and improve operations. We specialize in complex facilities in high-tech and highly regulated industries providing technical consulting, engineering, construction and commissioning and qualification. For over twenty years, we have applied LEAN techniques throughout the project life cycle, continually finding ways to do things better and more efficiently, delivering higher quality and controlling costs. Headquartered in Lafayette Hill, PA, IPS has branch offices in North Carolina, New Jersey, California, Indiana and India.

CONTACT:
Kate McCorriston
610.828.4090 ext. 1217

# # #

Read the full story at http://www.prweb.com/releases/IPS/Dave_Wareheim/prweb3467294.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
2. Codexis Appoints Singapore Laboratories Managing Director
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
6. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
7. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
8. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
9. NeurogesX Appoints New Director to the Board
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Pa., Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), the ... laboratory and production customers, today reported its financial results for ... Highlights: 4Q16 record quarterly ... 1.0% on an organic basis. ... an organic basis, while the Americas net sales increased 2.5%, ...
(Date:2/23/2017)... LONDON and NEW YORK ... at HIMSS, Lumeon , a leading digital ... (DN Telehealth), a provider of telemedicine and remote ... care pathways for telemedicine reimbursements.  ... and their patients, in real-time, extending consultations beyond ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... Drug Discovery Services portfolio to include an array of biochemical analyses critical ... reliable data to drive their hit-to-lead and SAR programs, including inhibitor potency and ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
Breaking Biology Technology:
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... The global synthetic-biology market ... billion by 2021, growing at a compound annual growth rate ... overview of the global markets for synthetic biology. - Analyses ... 2016, and projections of compound annual growth rates (CAGRs) through ...
(Date:2/7/2017)... BEACH, New York , February 7, 2017 /PRNewswire/ ... known as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" ... identity management and electronic transaction processing services, is pleased ... reorganization of the Company. Effective January 31, ... of the Board of Directors, CEO and President.  An ...
(Date:2/2/2017)... , Feb. 2, 2017  EyeLock LLC, a ... a new white paper " What You Should Know ... problem of ensuring user authenticity is a growing concern. ... authentication of users. However, traditional authentication schemes such as ... Biometric authentication offers an elegant solution to ...
Breaking Biology News(10 mins):